
Alumis Inc. is a precision medicines company with the mission to transform the lives of patients with autoimmune diseases. Even with treatment innovations of the last two decades, many patients with immunologic conditions continue to suffer - our goal is to fundamentally change the outcomes for these patients.
We are seeking an experienced Senior Manager, FP&A – Research & Technical Operations to join our team in a fast-paced, high-growth environment. This position will serve as a strategic finance business partner to the Research and Technical Operations organizations, supporting a growing portfolio of programs and operational priorities. In this role, you will play a critical part in driving planning and forecasting processes, delivering decision support for functional leadership, and assisting the Sr. Director of FP&A in overall planning strategy and execution. This position will also involve close interaction with the Accounting team during month-end close processes.
Responsibilities
Qualifications
Alumis Values
• We Elevate
• We Challenge
• We Nurture
This position is located in South San Francisco, CA and employees are expected to be onsite Tuesday-Thursday.
The salary range for this position is $165,000 USD to $200,000 USD annually. This salary range is an estimate, and the actual salary may vary based on the Company’s compensation practices.
Alumis Inc. is an equal opportunity employer.

At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.
We recognize that patients living with immune-mediated diseases need alternatives to currently available therapies. Despite recent advances and innovations in the treatment of immune-mediated diseases, many patients continue to suffer, cycling through currently approved therapies while looking for a solution that alleviates the debilitating impact of their disease without life-limiting side effects.
Addressing the needs of these patients is why we exist. We are pioneering a precision approach that leverages insights we derive from powerful data analytics to select the right target, right molecule, right indication, right patient, and right endpoint resulting in optimized outcomes for patients. We believe that combining our insights with an integrated approach to drug development will produce the next generation of treatments to address immune dysfunction.
Incubated by Foresite Labs, Alumis is led by a team of deeply experienced professionals who are devoted to transforming the lives of patients with immune-mediated diseases by developing a pipeline of transformative therapies.